c-Abl
c-abl oncogene 1, non-receptor tyrosine kinase
Download Product PDF
MSDS Download Product PDF
Antigen Preparation
The synthetic peptide corresponding to SH2 domain of c-Abl protein.
Background
"The c-Abl proto-oncogene encodes a protein tyrosine kinase that is located in the cytoplasm and nucleus. It is activated by certain DNA-damaging agents and regulates induction of the stress-activated c-Jun N-terminal protein kinase (SAPK). In chronic myelogenous leukemia and in a subset of acute lymphoblastic leukemias, the c-Abl proto-oncogene undergoes a (9;22) chromosomal translocation producing a novel rearranged chromosome (the Philadelphia chromosome) As the result of the fusion of c-Abl sequences from chromosome 9 to the Bcr gene on chromosome 22. The molecular consequence of this translocation is the generation of a chimeric Bcr/Abl mRNA encoding activated Abl protein tyrosine kinase."
PURIFICATION
The mouse IgG is purified by Protein A-Affinity Chromatography according to Isotyping
|
SPECIFICITY
This antibody recognizes c-Abl protein. It cross react to human and mouse. The other species was not tested.
|
FORMULATION
This affinity purified antibody is supplied in sterile Phosphatebuffered saline (pH7.2) containing antibody stabilizer
|
STORAGE
The antibodies are stable for 24 months from date of receipt when stored at –20oC to –70oC. The antibodies can be stored at 2oC-8oC for three month without detectable loss of activity. Avoid repeated freezing-thawing cycles.
|
Applications/Suggested Working Dilutions
|
|
Immunoprecipitation
2-5 µg/ml
|
|
Flow cytometry
Not tested
|